氫羥腎上腺皮質素 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "氫羥腎上腺皮質素" in Chinese language version.

refsWebsite

Global rank Chinese rank

21web.archive.org

1^st place

18nih.gov

4^th place

5^th place

15doi.org

2^nd place

23^rd place

8semanticscholar.org

11^th place

332^nd place

6books.google.com

3^rd place

8^th place

3drugs.com

399^th place

208^th place

3europa.eu

68^th place

209^th place

2clincalc.com

3,912^th place

5,917^th place

1tga.gov.au

3,984^th place

1,603^rd place

1s3.amazonaws.com

1,540^th place

4,109^th place

1google.com

163^rd place

188^th place

1handle.net

102^nd place

492^nd place

1mshpriceguide.org

low place

5,458^th place

1amjmed.com

low place

1healthify.nz

low place

1nhs.uk

1,989^th place

2,409^th place

1worldcat.org

5^th place

12^th place

1archive.org

6^th place

4^th place

amjmed.com

Brown, Ernest M.; Frain, J.Bruce. Locally administered hydrocortisone in the rheumatic diseases. The American Journal of Medicine. November 1953, 15 (5): 656–665 [2025-02-13]. doi:10.1016/0002-9343(53)90154-5.

archive.org

Oriba HA, Bucks DA, Maibach HI. Percutaneous absorption of hydrocortisone and testosterone on the vulva and forearm: effect of the menopause and site. The British Journal of Dermatology. February 1996, 134 (2): 229–233. PMID 8746334. S2CID 30076779. doi:10.1111/j.1365-2133.1996.tb07606.x.

books.google.com

Becker KL. Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. 2001: 762. ISBN 978-0-7817-1750-2. （原始内容存档于14 September 2016）（英语）.
Fischer J, Ganellin CR. Analogue-based Drug Discovery. John Wiley & Sons. 2006: 484 [2020-09-07]. ISBN 978-3-527-60749-5. （原始内容存档于2023-01-10）（英语）.
Arvat E, Falorni A. Cortisol Excess and Insufficiency. Frontiers of Hormone Research. S. Karger AG. 2016: 1-PA61 [2023-04-10]. ISBN 978-3-318-05840-6. （原始内容存档于2023-04-27）.
Ghizzoni L, Cappa M, Chrousos GP, Loche S, Maghnie M (编). Pediatric Adrenal Diseases: Workshop, May 16-18, 2010, Turin (Italy). Karger Medical and Scientific Publishers. 2011: 174– [2023-04-10]. ISBN 978-3-8055-9643-5. OCLC 1020003143. （原始内容存档于2023-04-10）.
Elks J. The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. 2014-11-14: 316. ISBN 978-1-4757-2085-3. （原始内容存档于2017-09-08）.
Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000: 524– [2020-06-19]. ISBN 978-3-88763-075-1. （原始内容存档于2023-01-10）.

clincalc.com

The Top 300 of 2022. ClinCalc. [2024-08-30]. （原始内容存档于2024-08-30）.
Hydrocortisone Drug Usage Statistics, United States, 2013 - 2022. ClinCalc. [2024-08-30].

doi.org

Czock D, Keller F, Rasche FM, Häussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clinical Pharmacokinetics. 2005, 44 (1): 61–98. PMID 15634032. S2CID 24458998. doi:10.2165/00003088-200544010-00003.
Lennernäs H, Skrtic S, Johannsson G. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors. Expert Opinion on Drug Metabolism & Toxicology. June 2008, 4 (6): 749–758. PMID 18611115. S2CID 73248541. doi:10.1517/17425255.4.6.749.
Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, Kim H. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. August 2013, 9 (1): 30. PMC 3765115 . PMID 23947590. doi:10.1186/1710-1492-9-30 .
Brown, Ernest M.; Frain, J.Bruce. Locally administered hydrocortisone in the rheumatic diseases. The American Journal of Medicine. November 1953, 15 (5): 656–665 [2025-02-13]. doi:10.1016/0002-9343(53)90154-5.
Leite FM, Longui CA, Kochi C, Faria CD, Borghi M, Calliari LE, Monte O. [Comparative study of prednisolone versus hydrocortisone acetate for treatment of patients with the classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency]. Arq Bras Endocrinol Metabol. February 2008, 52 (1): 101–8. PMID 18345402. doi:10.1590/s0004-27302008000100014  （Portuguese）.
Hicks, Caitlin W; Sweeney, Daniel A. Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock. Critical Care Medicine. January 2012, 40 (1): 10.197 [2025-02-13]. doi:10.1097/CCM.0b013e31822efa14.
Caldato MC, Fernandes VT, Kater CE. One-year clinical evaluation of single morning dose prednisolone therapy for 21-hydroxylase deficiency. Arquivos Brasileiros de Endocrinologia e Metabologia. October 2004, 48 (5): 705–712. PMID 15761542. S2CID 13986916. doi:10.1590/S0004-27302004000500017 .
Wester RC, Maibach HI. Percutaneous absorption of topical corticosteroids. Current Problems in Dermatology. 1993, 21: 45–60. ISBN 978-3-8055-5712-2. PMID 8299376. doi:10.1159/000422362.
Bormann JL, Maibach HI. Effects of anatomical location on in vivo percutaneous penetration in man. Cutaneous and Ocular Toxicology. September 2020, 39 (3): 213–222. PMID 32643443. S2CID 220439810. doi:10.1080/15569527.2020.1787434.
Wester RC, Maibach HI. Regional Variation in Percutaneous Absorption. Percutaneous Absorption. CRC Press. 2021-06-08: 165–174. ISBN 978-0-429-20297-1. S2CID 132864025. doi:10.1201/9780429202971-11.
Britz MB, Maibach HI, Anjo DM. Human percutaneous penetration of hydrocortisone: the vulva. Archives of Dermatological Research. 1980, 267 (3): 313–316. PMID 7406539. S2CID 33367289. doi:10.1007/BF00403852.
Oriba HA, Bucks DA, Maibach HI. Percutaneous absorption of hydrocortisone and testosterone on the vulva and forearm: effect of the menopause and site. The British Journal of Dermatology. February 1996, 134 (2): 229–233. PMID 8746334. S2CID 30076779. doi:10.1111/j.1365-2133.1996.tb07606.x.
Charmandari E, Johnston A, Brook CG, Hindmarsh PC. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. The Journal of Endocrinology. April 2001, 169 (1): 65–70. PMID 11250647. doi:10.1677/joe.0.1690065 .
Nikolaou N, Hodson L, Tomlinson JW. The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies. The Journal of Steroid Biochemistry and Molecular Biology. March 2021, 207: 105808. PMID 33418075. S2CID 230716310. doi:10.1016/j.jsbmb.2021.105808.
Sterne JA, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LC, Berwanger O, Cavalcanti AB, Dequin PF, Du B, Emberson J, Fisher D, Giraudeau B, Gordon AC, Granholm A, Green C, Haynes R, Heming N, Higgins JP, Horby P, Jüni P, Landray MJ, Le Gouge A, Leclerc M, Lim WS, Machado FR, McArthur C, Meziani F, Møller MH, Perner A, Petersen MW, Savovic J, Tomazini B, Veiga VC, Webb S, Marshall JC. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. October 2020, 324 (13): 1330–1341. PMC 7489434 . PMID 32876694. doi:10.1001/jama.2020.17023 .

drugs.com

Hydrocortisone. Drugs.com. American Society of Health-System Pharmacists. 2015-02-09 [2016-08-30]. （原始内容存档于2016-09-20）.
Hydrocortisone Pregnancy and Breastfeeding Warnings. Drugs.com. [2016-09-01]. （原始内容存档于2016-09-20）.
Dexamethasone. drugs.com. [2013-06-14]. （原始内容存档于2013-06-21）.

europa.eu

ema.europa.eu

Efmody EPAR. European Medicines Agency (EMA). 2021-03-24 [2021-06-14]. （原始内容存档于2021-06-14）. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
Efmody: Pending EC decision. European Medicines Agency (EMA). 2021-03-25 [2021-03-27]. （原始内容存档于2021-05-04）. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

ec.europa.eu

Efmody Product information. Union Register of medicinal products. [2023-03-03]. （原始内容存档于2023-03-05）.

google.com

美國專利第2,183,589号

handle.net

hdl.handle.net

World Health Organization. World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. hdl:10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

healthify.nz

Cortisone injections into joints. Healthify. [2025-02-13].

mshpriceguide.org

Hydrocortisone. International Drug Price Indicator Guide. [1 2016-09-01]. （原始内容存档于2018-08-27）.

nhs.uk

About hydrocortisone for skin. NHS. [2025-02-13].

nih.gov

ncbi.nlm.nih.gov

Czock D, Keller F, Rasche FM, Häussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clinical Pharmacokinetics. 2005, 44 (1): 61–98. PMID 15634032. S2CID 24458998. doi:10.2165/00003088-200544010-00003.
Lennernäs H, Skrtic S, Johannsson G. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors. Expert Opinion on Drug Metabolism & Toxicology. June 2008, 4 (6): 749–758. PMID 18611115. S2CID 73248541. doi:10.1517/17425255.4.6.749.
Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, Kim H. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. August 2013, 9 (1): 30. PMC 3765115 . PMID 23947590. doi:10.1186/1710-1492-9-30 .
Leite FM, Longui CA, Kochi C, Faria CD, Borghi M, Calliari LE, Monte O. [Comparative study of prednisolone versus hydrocortisone acetate for treatment of patients with the classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency]. Arq Bras Endocrinol Metabol. February 2008, 52 (1): 101–8. PMID 18345402. doi:10.1590/s0004-27302008000100014  （Portuguese）.
Caldato MC, Fernandes VT, Kater CE. One-year clinical evaluation of single morning dose prednisolone therapy for 21-hydroxylase deficiency. Arquivos Brasileiros de Endocrinologia e Metabologia. October 2004, 48 (5): 705–712. PMID 15761542. S2CID 13986916. doi:10.1590/S0004-27302004000500017 .
Wester RC, Maibach HI. Percutaneous absorption of topical corticosteroids. Current Problems in Dermatology. 1993, 21: 45–60. ISBN 978-3-8055-5712-2. PMID 8299376. doi:10.1159/000422362.
Bormann JL, Maibach HI. Effects of anatomical location on in vivo percutaneous penetration in man. Cutaneous and Ocular Toxicology. September 2020, 39 (3): 213–222. PMID 32643443. S2CID 220439810. doi:10.1080/15569527.2020.1787434.
Britz MB, Maibach HI, Anjo DM. Human percutaneous penetration of hydrocortisone: the vulva. Archives of Dermatological Research. 1980, 267 (3): 313–316. PMID 7406539. S2CID 33367289. doi:10.1007/BF00403852.
Oriba HA, Bucks DA, Maibach HI. Percutaneous absorption of hydrocortisone and testosterone on the vulva and forearm: effect of the menopause and site. The British Journal of Dermatology. February 1996, 134 (2): 229–233. PMID 8746334. S2CID 30076779. doi:10.1111/j.1365-2133.1996.tb07606.x.
Charmandari E, Johnston A, Brook CG, Hindmarsh PC. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. The Journal of Endocrinology. April 2001, 169 (1): 65–70. PMID 11250647. doi:10.1677/joe.0.1690065 .
Nikolaou N, Hodson L, Tomlinson JW. The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies. The Journal of Steroid Biochemistry and Molecular Biology. March 2021, 207: 105808. PMID 33418075. S2CID 230716310. doi:10.1016/j.jsbmb.2021.105808.
Sterne JA, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LC, Berwanger O, Cavalcanti AB, Dequin PF, Du B, Emberson J, Fisher D, Giraudeau B, Gordon AC, Granholm A, Green C, Haynes R, Heming N, Higgins JP, Horby P, Jüni P, Landray MJ, Le Gouge A, Leclerc M, Lim WS, Machado FR, McArthur C, Meziani F, Møller MH, Perner A, Petersen MW, Savovic J, Tomazini B, Veiga VC, Webb S, Marshall JC. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. October 2020, 324 (13): 1330–1341. PMC 7489434 . PMID 32876694. doi:10.1001/jama.2020.17023 .

dailymed.nlm.nih.gov

Ala-cort- hydrocortisone cream. DailyMed. [2021-02-21]. （原始内容存档于2020-10-27）.
Ala-scalp- hydrocortisone lotion. DailyMed. [2021-02-21]. （原始内容存档于2021-04-21）.
Alkindi Sprinkle- hydrocortisone granule. DailyMed. [2021-02-21]. （原始内容存档于2022-02-10）.
Anusol HC- hydrocortisone acetate suppository. DailyMed. [2021-02-21]. （原始内容存档于2022-02-10）.
Cortef- hydrocortisone tablet. DailyMed. [2021-02-21]. （原始内容存档于2021-04-17）.

pmc.ncbi.nlm.nih.gov

Hicks, Caitlin W; Sweeney, Daniel A. Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock. Critical Care Medicine. January 2012, 40 (1): 10.197 [2025-02-13]. doi:10.1097/CCM.0b013e31822efa14.

s3.amazonaws.com

Hydrocortisone Notice of enforcement policy (PDF). FDA. [2022-12-31]. （原始内容存档 (PDF)于2023-03-12）.

semanticscholar.org

api.semanticscholar.org

Czock D, Keller F, Rasche FM, Häussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clinical Pharmacokinetics. 2005, 44 (1): 61–98. PMID 15634032. S2CID 24458998. doi:10.2165/00003088-200544010-00003.
Lennernäs H, Skrtic S, Johannsson G. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors. Expert Opinion on Drug Metabolism & Toxicology. June 2008, 4 (6): 749–758. PMID 18611115. S2CID 73248541. doi:10.1517/17425255.4.6.749.
Caldato MC, Fernandes VT, Kater CE. One-year clinical evaluation of single morning dose prednisolone therapy for 21-hydroxylase deficiency. Arquivos Brasileiros de Endocrinologia e Metabologia. October 2004, 48 (5): 705–712. PMID 15761542. S2CID 13986916. doi:10.1590/S0004-27302004000500017 .
Bormann JL, Maibach HI. Effects of anatomical location on in vivo percutaneous penetration in man. Cutaneous and Ocular Toxicology. September 2020, 39 (3): 213–222. PMID 32643443. S2CID 220439810. doi:10.1080/15569527.2020.1787434.
Wester RC, Maibach HI. Regional Variation in Percutaneous Absorption. Percutaneous Absorption. CRC Press. 2021-06-08: 165–174. ISBN 978-0-429-20297-1. S2CID 132864025. doi:10.1201/9780429202971-11.
Britz MB, Maibach HI, Anjo DM. Human percutaneous penetration of hydrocortisone: the vulva. Archives of Dermatological Research. 1980, 267 (3): 313–316. PMID 7406539. S2CID 33367289. doi:10.1007/BF00403852.
Oriba HA, Bucks DA, Maibach HI. Percutaneous absorption of hydrocortisone and testosterone on the vulva and forearm: effect of the menopause and site. The British Journal of Dermatology. February 1996, 134 (2): 229–233. PMID 8746334. S2CID 30076779. doi:10.1111/j.1365-2133.1996.tb07606.x.
Nikolaou N, Hodson L, Tomlinson JW. The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies. The Journal of Steroid Biochemistry and Molecular Biology. March 2021, 207: 105808. PMID 33418075. S2CID 230716310. doi:10.1016/j.jsbmb.2021.105808.

tga.gov.au

Prescribing medicines in pregnancy database. Therapeutic Goods Administration (TGA). [2021-02-21]. （原始内容存档于2016-12-20）.

web.archive.org

Hydrocortisone. Drugs.com. American Society of Health-System Pharmacists. 2015-02-09 [2016-08-30]. （原始内容存档于2016-09-20）.
Prescribing medicines in pregnancy database. Therapeutic Goods Administration (TGA). [2021-02-21]. （原始内容存档于2016-12-20）.
Hydrocortisone Notice of enforcement policy (PDF). FDA. [2022-12-31]. （原始内容存档 (PDF)于2023-03-12）.
Ala-cort- hydrocortisone cream. DailyMed. [2021-02-21]. （原始内容存档于2020-10-27）.
Ala-scalp- hydrocortisone lotion. DailyMed. [2021-02-21]. （原始内容存档于2021-04-21）.
Alkindi Sprinkle- hydrocortisone granule. DailyMed. [2021-02-21]. （原始内容存档于2022-02-10）.
Anusol HC- hydrocortisone acetate suppository. DailyMed. [2021-02-21]. （原始内容存档于2022-02-10）.
Cortef- hydrocortisone tablet. DailyMed. [2021-02-21]. （原始内容存档于2021-04-17）.
Efmody EPAR. European Medicines Agency (EMA). 2021-03-24 [2021-06-14]. （原始内容存档于2021-06-14）. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
Efmody Product information. Union Register of medicinal products. [2023-03-03]. （原始内容存档于2023-03-05）.
Becker KL. Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. 2001: 762. ISBN 978-0-7817-1750-2. （原始内容存档于14 September 2016）（英语）.
Hydrocortisone Pregnancy and Breastfeeding Warnings. Drugs.com. [2016-09-01]. （原始内容存档于2016-09-20）.
Fischer J, Ganellin CR. Analogue-based Drug Discovery. John Wiley & Sons. 2006: 484 [2020-09-07]. ISBN 978-3-527-60749-5. （原始内容存档于2023-01-10）（英语）.
Hydrocortisone. International Drug Price Indicator Guide. [1 2016-09-01]. （原始内容存档于2018-08-27）.
The Top 300 of 2022. ClinCalc. [2024-08-30]. （原始内容存档于2024-08-30）.
Dexamethasone. drugs.com. [2013-06-14]. （原始内容存档于2013-06-21）.
Arvat E, Falorni A. Cortisol Excess and Insufficiency. Frontiers of Hormone Research. S. Karger AG. 2016: 1-PA61 [2023-04-10]. ISBN 978-3-318-05840-6. （原始内容存档于2023-04-27）.
Ghizzoni L, Cappa M, Chrousos GP, Loche S, Maghnie M (编). Pediatric Adrenal Diseases: Workshop, May 16-18, 2010, Turin (Italy). Karger Medical and Scientific Publishers. 2011: 174– [2023-04-10]. ISBN 978-3-8055-9643-5. OCLC 1020003143. （原始内容存档于2023-04-10）.
Elks J. The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. 2014-11-14: 316. ISBN 978-1-4757-2085-3. （原始内容存档于2017-09-08）.
Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000: 524– [2020-06-19]. ISBN 978-3-88763-075-1. （原始内容存档于2023-01-10）.
Efmody: Pending EC decision. European Medicines Agency (EMA). 2021-03-25 [2021-03-27]. （原始内容存档于2021-05-04）. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

worldcat.org

Ghizzoni L, Cappa M, Chrousos GP, Loche S, Maghnie M (编). Pediatric Adrenal Diseases: Workshop, May 16-18, 2010, Turin (Italy). Karger Medical and Scientific Publishers. 2011: 174– [2023-04-10]. ISBN 978-3-8055-9643-5. OCLC 1020003143. （原始内容存档于2023-04-10）.